Ignite Creation Date:
2024-05-06 @ 12:49 PM
Last Modification Date:
2024-10-26 @ 1:04 PM
Study NCT ID:
NCT03858972
Status:
TERMINATED
Last Update Posted:
2021-07-30
First Post:
2019-02-26
Brief Title:
Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative HR Positive LAMBC
Sponsor:
Organization:
Odonate Therapeutics Inc